CFDA Publishes Illegal Pharma, Device Advertising Report
This article was originally published in PharmAsia News
China FDA’s national report on illicit drug and medical device advertisements for the first quarter of 2013 showed investigations conducted on 36,747 ads for drugs, and 3,828 for devices, resulting in 37 advertising approval codes being revoked and 76 sales suspensions.
You may also be interested in...
The $250m deal adds A&E Medical’s sternal sutures, cable systems, and rigid fixation systems to Zimmer Biomet’s Dental, Spine & Craniomaxillofacial and Thoracic business.
The Phase III clinical trial showed a noticeable placebo effect compared with OV101.
The company will invest $1.2bn over the next four years to expand and upgrade its manufacturing capacity for pre-fillable syringes and advanced drug delivery systems across seven manufacturing facilities.